UBS maintains Colgate-Palmolive at Buy, raises price target to $112 from $106

What happened

UBS maintained its Buy rating on Colgate-Palmolive and raised its price target to $112 from $106, a 5.7% increase. The new target implies 15.0% upside from the November 2 close of $97.43.

Confirmed

Global impact / market context

A higher price target signals that UBS expects more upside in the shares, which can draw investor attention and support demand for the stock. Other recent analyst targets range from $97 to $111, so UBS now sits at the top of that range.

Analyst inference

Five recent analyst notes show mostly positive ratings but a wide target range of $97 to $111, which means views on how much the shares are worth differ. UBS raising its target suggests a more positive view on the company's prospects.

Analyst inference

What to watch

1. Watch whether other analysts change their Colgate-Palmolive ratings or price targets after UBS raised its target to $112 from $106. Confirmed
2. Watch for updates to the company's financial guidance or business plans that could support or challenge the higher price target UBS now assigns. Proposed
3. Watch whether the share price moves toward the $112 target, since the implied 15.0% upside depends on the stock staying near the $97.43 close. Analyst inference

Evidence

• Original source link unavailable